Posted
Apr 23, 2026
May 1, 2036
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
The Capability Program Executive for CBRND invites entities to participate in the HEALER portfolio under a Participant Basic Agreement to develop threat-agnostic host-directed therapeutics. Interested parties must submit a white paper of no more than five pages describing their product's efficacy, regulatory status, and manufacturing capabilities. This opportunity is managed by ACC Aberdeen Proving Ground and is currently active as a Special Notice for potential collaborators.
